Successful biotechnology Senior Executive with pharmaceutical leadership experience across multiple therapeutic franchises, including CNS, biosurgery, inflammation, fibrosis, cardiovascular, metabolism and infectious disease

Hank serves as the Chief Executive Officer of Generian and serves as Executive-in-Residence at UPMC Enterprises. Previously, he was founding CEO of Cognition Therapeutics, Inc. and Complexa, Inc. He is Board Director at Ariel Precision Medicine and Adjunct Professor at Carnegie Mellon University. Hank served as VP, Business Development for both Cognition Therapeutics, Inc. and Acorda Therapeutics, Inc. and was an Investment Advisor at Pittsburgh Life Sciences Greenhouse. Hank was also Director, Lifecycle Management, Metabolics Marketing and Director, Licensing, Cardiovascular with Bristol-Myers Squibb. From 1991-1997, he was Director, Technology Transfer at the National Heart, Lung and Blood Institute and Cooperative Venture Manager for the National Institute of Allergy and Infectious Diseases, National Institutes of Health. He was a Post-Doctoral Fellow at NIH and the Multiple Sclerosis Society. Hank received a BA in Biochemistry from Rutgers University, a PhD in Human Anatomy and Neurobiology from the University of Louisville, a JD from the American University, Washington College of Law and an MBA from Columbia University. He is a member of the Maryland Bar and is RAPS Certified.